Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion
Hilary A. Kenny, … , David Bowtell, Ernst Lengyel
Hilary A. Kenny, … , David Bowtell, Ernst Lengyel
Published September 9, 2014
Citation Information: J Clin Invest. 2014;124(10):4614-4628. https://doi.org/10.1172/JCI74778.
View: Text | PDF
Research Article Article has an altmetric score of 21

Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion

  • Text
  • PDF
Abstract

Ovarian cancer (OvCa) metastasizes to organs in the abdominal cavity, such as the omentum, which are covered by a single layer of mesothelial cells. Mesothelial cells are generally thought to be “bystanders” to the metastatic process and simply displaced by OvCa cells to access the submesothelial extracellular matrix. Here, using organotypic 3D cultures, we found that primary human mesothelial cells secrete fibronectin in the presence of OvCa cells. Moreover, we evaluated the tumor stroma of 108 human omental metastases and determined that fibronectin was consistently overexpressed in these patients. Blocking fibronectin production in primary mesothelial cells in vitro or in murine models, either genetically (fibronectin 1 floxed mouse model) or via siRNA, decreased adhesion, invasion, proliferation, and metastasis of OvCa cells. Using a coculture model, we determined that OvCa cells secrete TGF-β1, which in turn activates a TGF-β receptor/RAC1/SMAD-dependent signaling pathway in the mesothelial cells that promotes a mesenchymal phenotype and transcriptional upregulation of fibronectin. Additionally, blocking α5 or β1 integrin function with antibodies reduced metastasis in an orthotopic preclinical model of OvCa metastasis. These findings indicate that cancer-associated mesothelial cells promote colonization during the initial steps of OvCa metastasis and suggest that mesothelial cells actively contribute to metastasis.

Authors

Hilary A. Kenny, Chun-Yi Chiang, Erin A. White, Elizabeth M. Schryver, Mohammed Habis, Iris L. Romero, Andras Ladanyi, Carla V. Penicka, Joshy George, Karl Matlin, Anthony Montag, Kristen Wroblewski, S. Diane Yamada, Andrew P. Mazar, David Bowtell, Ernst Lengyel

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2010 2009 Total
Citations: 3 17 22 23 30 18 24 25 15 13 12 1 1 204
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (204)

Title and authors Publication Year
The extracellular matrix protein type I collagen and fibronectin are regulated by β-arrestin-1/endothelin axis in human ovarian fibroblasts
Masi I, Ottavi F, Caprara V, Rio DD, Kunkl M, Spadaro F, Licursi V, Tuosto L, Bagnato A, Rosano\u2019 L
Journal of Experimental & Clinical Cancer Research : CR 2025
Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements.
Wang Y, Zhu N, Liu J, Chen F, Song Y, Ma Y, Yang Z, Wang D
Journal of translational medicine 2025
Interplay of integrins and selectins in metastasis
Maltseva D, Nersisyan A, Tonevitsky A
Molecular Oncology 2025
Secretory factors from omental preadipocytes support ovarian cancer tumorigenesis via matrix remodeling and IGF signaling
Jennifer Waters, Mikella Robinson, Omar Lujano-Olazaba, Samuel F Gilbert, Carrie House
Cancer research 2024
HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodeling
Terri M, Sandoval P, Bontempi G, Montaldo C, Tomero-Sanz H, de Turris V, Trionfetti F, Pascual-Antón L, Clares-Pedrero I, Battistelli C, Valente S, Zwergel C, Mai A, Rosanò L, del Pozo MÁ, Sánchez-Álvarez M, Cabañas C, Tripodi M, López-Cabrera M, Strippoli R
Journal of experimental & clinical cancer research : CR 2024
Obesity modulates the cellular and molecular microenvironment in the peritoneal cavity: implication for ovarian cancer risk
Shea AA, Heffron CL, Grieco JP, Roberts PC, Schmelz EM
Frontiers in immunology 2024
Blockade of CD93 in pleural mesothelial cells fuels anti-lung tumor immune responses
Zhang C, Nan X, Zhang B, Wu H, Zeng X, Song Z, Li S, Wang J, Xie S, Zhang G, Xiu H, Wang J, Guo J, Wang P, Cai Z, Zhen Y, Shen Y
Theranostics 2024
A Recipe for Successful Metastasis: Transition and Migratory Modes of Ovarian Cancer Cells
Śliwa A, Szczerba A, Pięta PP, Białas P, Lorek J, Nowak-Markwitz E, Jankowska A
Cancers 2024
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease
Ramachandran D, Tyrer JP, Kommoss S, DeFazio A, Riggan MJ, Webb PM, Fasching PA, Lambrechts D, García MJ, Rodríguez-Antona C, Goodman MT, Modugno F, Moysich KB, Karlan BY, Lester J, Kjaer SK, Jensen A, Høgdall E, Goode EL, Cliby WA, Kumar A, Wang C, Cunningham JM, Winham SJ, Monteiro AN, Schildkraut JM, Cramer DW, Terry KL, Titus L, Bjorge L, Thomsen LC, Pejovic T, Høgdall CK, McNeish IA, May T, Huntsman DG, Pfisterer J, Canzler U, Park-Simon TW, Schröder W, Belau A, Hanker L, Harter P, Sehouli J, Kimmig R, de Gregorio N, Schmalfeldt B, Baumann K, Hilpert F, Burges A, Winterhoff B, Schürmann P, Speith LM, Hillemanns P, Berchuck A, Johnatty SE, Ramus SJ, Chenevix-Trench G, Pharoah PD, Dörk T, Heitz F
npj Genomic Medicine 2024
Tumor-associated fibrosis: a unique mechanism promoting ovarian cancer metastasis and peritoneal dissemination.
Fujimoto H, Yoshihara M, Rodgers R, Iyoshi S, Mogi K, Miyamoto E, Hayakawa S, Hayashi M, Nomura S, Kitami K, Uno K, Sugiyama M, Koya Y, Yamakita Y, Nawa A, Enomoto A, Ricciardelli C, Kajiyama H
Cancer metastasis reviews 2024
Ovarian tumor cell-derived JAGGED2 promotes omental metastasis through stimulating the Notch signaling pathway in the mesothelial cells.
Islam SS, Al-Mohanna FH, Yousef IM, Al-Badawi IA, Aboussekhra A
Cell Death and Disease 2024
Reciprocal crosstalk between Th17 and mesothelial cells promotes metastasis‐associated adhesion of ovarian cancer cells
Neuhaus F, Lieber S, Shinkevich V, Steitz AM, Raifer H, Roth K, Finkernagel F, Worzfeld T, Burchert A, Keber C, Nist A, Stiewe T, Reinartz S, Beutgen VM, Graumann J, Pauck K, Garn H, Gaida M, Müller R, Huber M
Clinical and Translational Medicine 2024
The role of Piezo1 mechanotransduction in high-grade serous ovarian cancer: Insights from an in vitro model of collective detachment.
Micek HM, Yang N, Dutta M, Rosenstock L, Ma Y, Hielsberg C, McCord M, Notbohm J, McGregor S, Kreeger PK
Science Advances 2024
Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemness
Battistini C, Kenny HA, Zambuto M, Nieddu V, Melocchi V, Decio A, Lo Riso P, Villa CE, Gatto A, Ghioni M, Porta FM, Testa G, Giavazzi R, Colombo N, Bianchi F, Lengyel E, Cavallaro U
Cell Death and Disease 2024
Enhancing PKA-dependent mesothelial barrier integrity reduces ovarian cancer transmesothelial migration via inhibition of contractility
Jazwinska DE, Cho Y, Zervantonakis IK
iScience 2024
Exploiting Matrix Stiffness to Overcome Drug Resistance.
Aydin HB, Ozcelikkale A, Acar A
ACS Biomaterials Science & Engineering 2024
Recent Progress in the Application of Exosome Analysis in Ovarian Cancer Management.
Keyvani V, Ghale-Noie ZN, Mollazadeh S, Mahmoudian RA, Ghorbani E, Naderi H, Khazaei M, Hassanian SM, Ferns GA, Avan A, Anvari K
Current cancer drug targets 2024
Macrophage diversity in cancer dissemination and metastasis.
Mantovani A, Marchesi F, Di Mitri D, Garlanda C
Cellular & molecular immunology 2024
Gene Profiling of Circular RNAs in Keloid-prone Individuals and ceRNA Network Construction During Wound Healing.
Yang J, Zhu Z, Xu Y, Xu S, Zhang Y, Liu Z, Liu X, Shi J, Han B
Aesthetic plastic surgery 2024
Interleukin-6 Modulation in Ovarian Cancer Necessitates a Targeted Strategy: From the Approved to Emerging Therapies
Amer H, Kampan NC, Itsiopoulos C, Flanagan KL, Scott CL, Kartikasari AE, Plebanski M
Cancers 2024
Cancer-Associated Mesothelial Cell-Derived ANGPTL4 Promotes the Early Steps of Ovarian Cancer Metastasis
Preety Bajwa, Kasjusz Kordylewicz, Agnes Bilecz, Ricardo Lastra, Kristen Wroblewski, Yuval Rinkevich, Ernst Lengyel, Hilary Kenny
JCI Insight 2023
Patient-Derived In Vitro Models of Ovarian Cancer: Powerful Tools to Explore the Biology of the Disease and Develop Personalized Treatments
Battistini C, Cavallaro U
Cancers 2023
Tumor microenvironment in ovarian cancer peritoneal metastasis
Mei S, Chen X, Wang K, Chen Y
Cancer Cell International 2023
Mitochondrial plasticity supports proliferative outgrowth and invasion of ovarian cancer spheroids during adhesion
Grieco JP, Compton SL, Bano N, Brookover L, Nichenko AS, Drake JC, Schmelz EM
Frontiers in Oncology 2023
Macrophages Promote Ovarian Cancer-Mesothelial Cell Adhesion by Upregulation of ITGA2 and VEGFC in Mesothelial Cells
Cho SK, Lee K, Woo JH, Choi JH
Cells 2023
Model of collective detachment in high-grade serous ovarian cancer demonstrates that tumor spheroids produce ECM to support metastatic processes
Micek HM, Rosenstock L, Ma Y, Hielsberg C, Montemorano L, Gari MK, Ponik SM, Kreeger PK
2023
Insights into high-grade serous carcinoma pathobiology using three-dimensional culture model systems.
Tomas E, Shepherd TG
Journal of Ovarian Research 2023
Cancer stem cells: an insight into the development of metastatic tumors and therapy resistance.
Nairuz T, Mahmud Z, Manik RK, Kabir Y
Stem Cell Reviews and Reports 2023
Intraperitoneal metastasis of ovarian cancer: new insights on resident macrophages in the peritoneal cavity
Miyamoto T, Murphy B, Zhang N
Frontiers in immunology 2023
Role of Exosomes in the Invasion and Metastasis of Ovarian Cancer and Application Potential of Clinical Diagnosis and Treatment
Zhu Y, Wang C, Ma Z, Li F, Xu C, Pan W, Liu A
Journal of Cancer 2023
TMTC1 promotes invasiveness of ovarian cancer cells through integrins β1 and β4.
Yeh TC, Lin NY, Chiu CY, Hsu TW, Wu HY, Lin HY, Chen CH, Huang MC
Cancer Gene Therapy 2023
Cancer cell‐derived CD69 induced under lipid and oxygen starvation promotes ovarian cancer progression through fibronectin
Koizume S, Kanayama T, Kimura Y, Hirano H, Takahashi T, Ota Y, Miyazaki K, Yoshihara M, Nakamura Y, Yokose T, Kato H, Takenaka K, Sato S, Tadokoro H, Miyagi E, Miyagi Y
Cancer Science 2023
“DEPHENCE” system—a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer—a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies
Wilczyński JR, Wilczyński M, Paradowska E
Frontiers in Oncology 2023
Fibronectin contributes to a BRAF inhibitor-driven invasive phenotype in thyroid cancer through EGR1, which can be blocked by inhibition of ERK1/2.
Hicks HM, Pozdeyev N, Sams SB, Pugazhenthi U, Bales ES, Hofmann MC, McKenna LR, Schweppe RE
Molecular cancer research : MCR 2023
Regional Immunotherapy for Peritoneal Carcinomatosis in Gastroesophageal Cancer: Emerging Strategies to Re-Condition a Maladaptive Tumor Environment
Lewis CR, Dadgar N, Yellin SA, Donnenberg VS, Donnenberg AD, Bartlett DL, Allen CJ, Wagner PL
Cancers 2023
Cancer-mesothelial and cancer-macrophage interactions in the ovarian cancer microenvironment
Jazwinska DE, Kulawiec DG, Zervantonakis IK
AJP Cell Physiology 2023
Revisiting the Use of Normal Saline for Peritoneal Washing in Ovarian Cancer
Akasaka H, Naora H
International journal of molecular sciences 2023
Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in ovarian cancer
Dondi A, Lischetti U, Jacob F, Singer F, Borgsmüller N, Coelho R, Heinzelmann-Schwarz V, Beisel C, Beerenwinkel N
Nature Communications 2023
DDR2-regulated arginase activity in ovarian cancer-associated fibroblasts promotes collagen production and tumor progression.
Akinjiyan FA, Ibitoye Z, Zhao P, Shriver LP, Patti GJ, Longmore GD, Fuh KC
Oncogene 2023
Adipocyte Microenvironment in Ovarian Cancer: A Critical Contributor?
Duarte Mendes A, Freitas AR, Vicente R, Vitorino M, Vaz Batista M, Silva M, Braga S
International journal of molecular sciences 2023
Ovarian cancer relies on the PDGFRβ–fibronectin axis for tumorsphere formation and metastatic spread
Gendrau\u2010Sanclemente N, Figueras A, Gracova K, Lahiguera Á, Alsina\u2010Sanchís E, Marín\u2010Jiménez JA, Vidal A, Matias\u2010Guiu X, Fernandez\u2010Gonzalez S, Barahona M, Martí L, Ponce J, Viñals F
Molecular Oncology 2023
Stromal DDR2 promotes ovarian cancer metastasis through regulation of metabolism and secretion of extracellular matrix proteins
Schab AM, Greenwade MM, Stock E, Lomonosova E, Cho K, Grither WR, Noia H, Wilke D, Mullen MM, Hagemann AR, Hagemann IS, Thaker PH, Kuroki LM, McCourt CK, Khabele D, Powell MA, Mutch DG, Zhao P, Shriver LP, Patti GJ, Longmore GD, Fuh KC
Molecular cancer research : MCR 2023
Ovarian Cancer Cells in Ascites Form Aggregates That Display a Hybrid Epithelial-Mesenchymal Phenotype and Allows Survival and Proliferation of Metastasizing Cells
S Capellero, J Erriquez, C Battistini, R Porporato, G Scotto, F Borella, M Renzo, G Valabrega, M Olivero
International journal of molecular sciences 2022
MiR-29b may suppresses peritoneal metastases through inhibition of the mesothelial–mesenchymal transition (MMT) of human peritoneal mesothelial cells
Y Kimura, H Ohzawa, H Miyato, Y Kaneko, A Saito, K Takahashi, M Tojo, H Yamaguchi, K Kurashina, S Saito, Y Hosoya, A Lefor, N Sata, J Kitayama
Scientific Reports 2022
Carrier-free multifunctional nanomedicine for intraperitoneal disseminated ovarian cancer therapy
X Huang, M Qiu, T Wang, B Li, S Zhang, T Zhang, P Liu, Q Wang, Z Qian, C Zhu, M Wu, J Zhao
Journal of nanobiotechnology 2022
Three-Dimensional Modelling of Ovarian Cancer: From Cell Lines to Organoids for Discovery and Personalized Medicine
C Yee, K Dickson, M Muntasir, Y Ma, D Marsh
Frontiers in Bioengineering and Biotechnology 2022
Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel Therapies
J Wilczyński, M Wilczyński, E Paradowska
International journal of molecular sciences 2022
The functional multipotency of transforming growth factor β signaling at the intersection of senescence and cancer
J Mikuła-Pietrasik, S Rutecki, K Książek
Cellular and Molecular Life Sciences 2022
Polymeric Hydrogels for In Vitro 3D Ovarian Cancer Modeling
S Braccini, C Tacchini, F Chiellini, D Puppi
International journal of molecular sciences 2022
Novel Ex Vivo Models of Epithelial Ovarian Cancer: The Future of Biomarker and Therapeutic Research
J Clark, C Fotopoulou, P Cunnea, J Krell
Frontiers in Oncology 2022
Epigenomic Profiling of Epithelial Ovarian Cancer Stem-Cell Differentiation Reveals GPD1 Associated Immune Suppressive Microenvironment and Poor Prognosis
L Chen, R Huang, P Su, L Chu, Y Weng, H Wang, H Lai, K Wen
International journal of molecular sciences 2022
Ovulation Enhances Intraperitoneal and Ovarian Seedings of High-Grade Serous Carcinoma Cells Originating from the Fallopian Tube: Confirmation in a Bursa-Free Mouse Xenograft Model
Hsu CF, Seenan V, Wang LY, Chu TY
International journal of molecular sciences 2022
The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination
Ritch SJ, Telleria CM
Frontiers in Endocrinology 2022
Quantitative biophysical metrics for rapid evaluation of ovarian cancer metastatic potential
Mukherjee A, Zhang H, Ladner K, Brown M, Urbanski J, Grieco JP, Kapania RK, Lou E, Behkam B, Schmelz EM, Nain AS
Molecular biology of the cell 2022
DDR2 Expression in Cancer-Associated Fibroblasts Promotes Ovarian Cancer Tumor Invasion and Metastasis through Periostin-ITGB1
Akinjiyan FA, Dave RM, Alpert E, Longmore GD, Fuh KC
Cancers 2022
Tissue transglutaminase activates integrin-linked kinase and β-catenin in ovarian cancer
Condello S, Prasad M, Atwani R, Matei D
The Journal of biological chemistry 2022
Pigment epithelium-derived factor promotes peritoneal dissemination of ovarian cancer through induction of immunosuppressive macrophages.
Ueno S, Sudo T, Saya H, Sugihara E
2022
Alpha-Mangostin Reduces Pericellular Fibronectin on Suspended Tumor Cells and Therapeutically, but Not Prophylactically, Suppresses Distant Metastasis
Huang LT, Kuo CH, Tseng L, Li YS, Cheng LH, Cheng CY, Sheu SR, Chang WT, Chen CC, Cheng HC
Life Sciences 2022
Increasing cancer permeability by photodynamic priming: from microenvironment to mechanotransduction signaling.
Carigga Gutierrez NM, Pujol-Solé N, Arifi Q, Coll JL, le Clainche T, Broekgaarden M
Cancer metastasis reviews 2022
Polarity switching of ovarian cancer cell clusters via SRC family kinase is involved in the peritoneal dissemination
Kawata M, Kondo J, Onuma K, Ito Y, Yokoi T, Hamanishi J, Mandai M, Kimura T, Inoue M
Cancer Science 2022
The role of cancer-associated mesothelial cells in the progression and therapy of ovarian cancer
Zheng A, Wei Y, Zhao Y, Zhang T, Ma X
Frontiers in immunology 2022
Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial Cells.
Lennartz M, Atug D, Dwertmann Rico S, Reiswich V, Viehweger F, Büscheck F, Kluth M, Hube-Magg C, Hinsch A, Bernreuther C, Sauter G, Burandt E, Marx AH, Krech T, Simon R, Minner S, Clauditz TS, Jacobsen F, Lebok P, Gorbokon N, Möller K, Steurer S, Fraune C
2022
Laminins in tumor-derived exosomes upregulated by ETS1 reprogram omental macrophages to promote omental metastasis of ovarian cancer
Li H, Zeng C, Shu C, Cao Y, Shao W, Zhang M, Cao H, Zhao S
Cell Death and Disease 2022
L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary
Doberstein K, Spivak R, Reavis HD, Hooda J, Feng Y, Kroeger PT Jr, Stuckelberger S, Mills GB, Devins KM, Schwartz LE, Iwanicki MP, Fogel M, Altevogt P, Drapkin R
Communications biology 2022
PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome
Salvi A, Hardy LR, Heath KN, Watry S, Pergande MR, Cologna SM, Burdette JE
Neoplasia (New York, N.Y.) 2022
Cancer associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling
Jin Qian, Bauer L. LeSavage, Kelsea M. Hubka, Chenkai Ma, Suchitra Natarajan, Joshua T Eggold, Yiren Xiao, Katherine C Fuh, Venkatesh Krishnan, Annika Enejder, Sarah Heilshorn, Oliver Dorigo, Erinn B. Rankin
Journal of Clinical Investigation 2021
Modelling TGFβR and Hh pathway regulation of prognostic matrisome molecules in ovarian cancer
RM Delaine-Smith, E Maniati, B Malacrida, S Nichols, R Roozitalab, RR Jones, LS Lecker, OM Pearce, MM Knight, FR Balkwill
iScience 2021
The Adipokine Component in the Molecular Regulation of Cancer Cell Survival, Proliferation and Metastasis
MI Umar, W Hassan, G Murtaza, M Buabeid, E Arafa, HM Irfan, MZ Asmawi, X Huang
Pathology oncology research : POR 2021
Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells–Peritoneal Stroma Interactions
M Terri, F Trionfetti, C Montaldo, M Cordani, M Tripodi, M Lopez-Cabrera, R Strippoli
Frontiers in immunology 2021
Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance
EA Pietilä, J Gonzalez-Molina, L Moyano-Galceran, S Jamalzadeh, K Zhang, L Lehtinen, SP Turunen, TA Martins, O Gultekin, T Lamminen, K Kaipio, U Joneborg, J Hynninen, S Hietanen, S Grénman, R Lehtonen, S Hautaniemi, O Carpén, JW Carlson, K Lehti
Nature Communications 2021
TGFβ signaling networks in ovarian cancer progression and plasticity
A Kumari, Z Shonibare, M Monavarian, RC Arend, NY Lee, GJ Inman, K Mythreye
Clinical & Experimental Metastasis 2021
Exploring the clinical value of tumor microenvironment in platinum-resistant ovarian cancer
A Ghoneum, S Almousa, B Warren, AY Abdulfattah, J Shu, H Abouelfadl, D Gonzalez, C Livingston, N Said
Seminars in Cancer Biology 2021
Personalized Models of Heterogenous 3D Epithelial Tumor Microenvironments: Ovarian Cancer as a Model
E Horst, M Bregenzer, P Mehta, C Snyder, T Repetto, Y Yang-Hartwich, G Mehta
Acta Biomaterialia 2021
Topological defects in the mesothelium suppress ovarian cancer cell clearance
J Zhang, N Yang, PK Kreeger, J Notbohm
2021
Ovarian Cancer-Driven Mesothelial-to-Mesenchymal Transition is Triggered by the Endothelin-1/β-arr1 Axis
DD Rio, I Masi, V Caprara, F Spadaro, F Ottavi, R Strippoli, P Sandoval, M López-Cabrera, RS de la Cuesta, A Bagnato, L Rosanò
Frontiers in Cell and Developmental Biology 2021
Ovarian Cancer-Associated Mesothelial Cells: Transdifferentiation to Minions of Cancer and Orchestrate Developing Peritoneal Dissemination
K Mogi, M Yoshihara, S Iyoshi, K Kitami, K Uno, S Tano, Y Koya, M Sugiyama, Y Yamakita, A Nawa, H Tomita, H Kajiyama
Cancers 2021
Characterization of TGFβ-associated molecular features and drug responses in gastrointestinal adenocarcinoma
Q Zhang, F Liu, L Qin, Z Liao, J Song, H Liang, X Chen, Z Zhang, B Zhang
BMC Gastroenterology 2021
Small extracellular vesicles from malignant ascites of patients with advanced ovarian cancer provide insights into the dynamics of the extracellular matrix
B Bortot, M Apollonio, E Rampazzo, F Valle, M Brucale, A Ridolfi, B Ura, R Addobbati, GD Lorenzo, F Romano, F Buonomo, C Ripepi, G Ricci, S Biffi
Molecular Oncology 2021
Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer
L Pascual-Antón, B Cardeñes, RS de la Cuesta, L González-Cortijo, M López-Cabrera, C Cabañas, P Sandoval
International journal of molecular sciences 2021
The Natural Product β-Escin Targets Cancer and Stromal Cells of the Tumor Microenvironment to Inhibit Ovarian Cancer Metastasis
HA Kenny, PC Hart, K Kordylewicz, M Lal, M Shen, B Kara, YJ Chen, N Grassl, Y Alharbi, BR Pattnaik, KM Watters, MS Patankar, M Ferrer, E Lengyel
Cancers 2021
Malignant Ascites Promote Adhesion of Ovarian Cancer Cells to Peritoneal Mesothelium and Fibroblasts
P Uruski, J Mikuła-Pietrasik, M Pakuła, S Budkiewicz, M Drzewiecki, AN Gaiday, M Wierzowiecka, E Naumowicz, R Moszyński, A Tykarski, K Książek
International journal of molecular sciences 2021
Ovarian-Cancer-Associated Extracellular Vesicles: Microenvironmental Regulation and Potential Clinical Applications
PK Croft, S Sharma, N Godbole, GE Rice, C Salomon
Cells 2021
Aberrant Methylation and Immune Microenvironment Are Associated With Overexpressed Fibronectin 1: A Diagnostic and Prognostic Target in Head and Neck Squamous Cell Carcinoma
S Sheng, B Guo, Z Wang, Z Zhang, J Zhou, Z Huo
Frontiers in Molecular Biosciences 2021
Genomic Analysis of Vascular Invasion in HCC Reveals Molecular Drivers and Predictive Biomarkers
MS Krishnan, AR KD, J Park, V Arjunan, FJ Marques, A Bermudez, OA Girvan, NS Hoang, J Yin, MH Nguyen, N Kothary, S Pitteri, DW Felsher, R Dhanasekaran
Hepatology 2021
The Interaction between Reactive Peritoneal Mesothelial Cells and Tumor Cells via Extracellular Vesicles Facilitates Colorectal Cancer Dissemination
S Serratì, L Porcelli, F Fragassi, M Garofoli, RD Fonte, L Fucci, RM Iacobazzi, A Palazzo, F Margheri, G Cristiani, A Albano, RD Luca, DF Altomare, M Simone, A Azzariti
Cancers 2021
Emerging Functions and Clinical Applications of Exosomal ncRNAs in Ovarian Cancer
Y Zhang, YJ Wei, YF Zhang, HW Liu, YF Zhang
Frontiers in Oncology 2021
The multicellular signalling network of ovarian cancer metastases
L Sommerfeld, F Finkernagel, JM Jansen, U Wagner, A Nist, T Stiewe, S MüllerBrüsselbach, AM Sokol, J Graumann, S Reinartz, R Müller
Clinical and Translational Medicine 2021
Host Mesothelin Expression Increases Ovarian Cancer Metastasis in the Peritoneal Microenvironment
TS Hilliard, B Kowalski, K Iwamoto, EA Agadi, Y Liu, J Yang, M Asem, Y Klymenko, J Johnson, Z Shi, G Marfowaa, MG Yemc, P Petrasko, MS Stack
International journal of molecular sciences 2021
Modeling the Tumor Microenvironment of Ovarian Cancer: The Application of Self-Assembling Biomaterials
AK Mendoza-Martinez, D Loessner, A Mata, HS Azevedo
Cancers 2021
Matrine inhibits ovarian cancer cell viability and promotes apoptosis by regulating the ERK/JNK signaling pathway via p38MAPK
X Liang, J Ju
Oncology reports 2021
Ovarian Cancer: Methods and Protocols
PK Kreeger
2021
Ovarian Cancer: Methods and Protocols
PK Kreeger
2021
HIF-1α Is a Rational Target for Future Ovarian Cancer Therapies
X Wang, Z Du, T Xu, X Wang, W Li, J Gao, J Li, H Zhu
Frontiers in Oncology 2021
Amelioration of human peritoneal mesothelial cell co-culture-evoked malignant potential of ovarian cancer cells by acacetin involves LPA release-activated RAGE-PI3K/AKT signaling
M Tian, Y Tang, T Huang, Y Liu, Y Pan
Cellular & Molecular Biology Letters 2021
Effects of integrin-linked kinase on protein kinase b, glycogen synthase kinase-3β, and β-catenin molecules in ovarian cancer cells
Seda Mehtap Sarı Kılıçaslan, Zerrin İncesu
Iranian Journal of Basic Medical Sciences 2021
Fibroblast subtypes define a metastatic matrisome in breast cancer
Heather M. Brechbuhl, Alexander S. Barrett, Etana Kopin, Jaime C. Hagen, Amy L. Han, Austin E. Gillen, Jessica Finlay-Schultz, Diana M. Cittelly, Philip Owens, Kathryn B. Horwitz, Carol A. Sartorius, Kirk C. Hansen, Peter Kabos
JCI Insight 2020
A Novel Role for NUAK1 in Promoting Ovarian Cancer Metastasis through Regulation of Fibronectin Production in Spheroids
JL Fritz, O Collins, P Saxena, A Buensuceso, YR Valdes, KE Francis, KR Brown, B Larsen, K Colwill, AC Gingras, R Rottapel, TG Shepherd
Cancers 2020
Shaping Up the Tumor Microenvironment With Cellular Fibronectin
G Efthymiou, A Saint, M Ruff, Z Rekad, D Ciais, EV Obberghen-Schilling
Frontiers in Oncology 2020
Molecular mediators of peritoneal metastasis in pancreatic cancer
LR Avula, B Hagerty, C Alewine
Cancer and Metastasis Reviews 2020
The influence of secreted factors and extracellular vesicles in ovarian cancer metastasis
M Hergueta-Redondo, H Peinado
European Journal of Cancer Supplements 2020
Omental macrophages secrete chemokine ligands that promote ovarian cancer colonization of the omentum via CCR1
V Krishnan, S Tallapragada, B Schaar, K Kamat, AM Chanana, Y Zhang, S Patel, V Parkash, C Rinker-Schaeffer, AK Folkins, EB Rankin, O Dorigo
2020
Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis
YL Huang, CY Liang, D Ritz, R Coelho, D Septiadi, M Estermann, C Cumin, N Rimmer, A Schötzau, MN López, A Fedier, M Konantz, T Vlajnic, D Calabrese, C Lengerke, L David, B Rothen-Rutishauser, F Jacob, V Heinzelmann-Schwarz
eLife 2020
Extracellular Matrix Derived from High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells through αvβ3 Integrin
RM Brandão-Costa, E Helal-Neto, AM Vieira, P Barcellos-de-Souza, J Morgado-Diaz, C Barja-Fidalgo
International journal of molecular sciences 2020
The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis
K Noh, DH Bach, HJ Choi, MS Kim, SY Wu, S Pradeep, C Ivan, MS Cho, E Bayraktar, C Rodriguez-Aguayo, SK Dasari, E Stur, LS Mangala, G Lopez-Berestein, AK Sood
Oncogene 2020
Orthogonal Proteomic Platforms and Their Implications for the Stable Classification of High-Grade Serous Ovarian Cancer Subtypes
SN Thomas, B Friedrich, M Schnaubelt, DW Chan, H Zhang, R Aebersold
iScience 2020
Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer
KA Kujawa, E Zembala-Nożyńska, AJ Cortez, T Kujawa, J Kupryjańczyk, KM Lisowska
Cells 2020
Biomimetic device and foreign body reaction cooperate for efficient tumour cell capture in murine advanced ovarian cancer
L Alonso-Alconada, A de la Fuente, M Santacana, A Ferreiros, R Lopez-Lopez, X Matias-Guiu, M Abal
Disease models & mechanisms 2020
Role of Epithelial–Mesenchymal Plasticity in Pseudomyxoma Peritonei: Implications for Locoregional Treatments
ML Calabrò, N Lazzari, G Rigotto, M Tonello, A Sommariva
International journal of molecular sciences 2020
Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
JD Hebert, SA Myers, A Naba, G Abbruzzese, JM Lamar, SA Carr, RO Hynes
Cancer research 2020
Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma
HF Berg, Z Ju, M Myrvold, KE Fasmer, MK Halle, EA Hoivik, SN Westin, J Trovik, IS Haldorsen, GB Mills, C Krakstad, HM Werner
British Journal of Cancer 2020
Patient-derived and artificial ascites have minor effects on MeT-5A mesothelial cells and do not facilitate ovarian cancer cell adhesion
M Estermann, YL Huang, D Septiadi, D Ritz, CY Liang, F Jacob, B Drasler, A Petri-Fink, V Heinzelmann-Schwarz, B Rothen-Rutishauser, S Ahmad
PloS one 2020
PDK1 promotes ovarian cancer metastasis by modulating tumor-mesothelial adhesion, invasion, and angiogenesis via α5β1 integrin and JNK/IL-8 signaling
MK Siu, Y Jiang, J Wang, TH Leung, SF Ngu, AN Cheung, HY Ngan, KK Chan
Oncogenesis 2020
Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesion
K Ojasalu, C Brehm, K Hartung, M Nischak, F Finkernagel, P Rexin, A Nist, E Pavlakis, T Stiewe, JM Jansen, U Wagner, S Gattenlöhner, A Bräuninger, S MüllerBrüsselbach, S Reinartz, R Müller
Molecular Oncology 2020
SPHK1 Is a Novel Target of Metformin in Ovarian Cancer
PC Hart, T Chiyoda, X Liu, M Weigert, M Curtis, CY Chiang, R Loth, R Lastra, SM McGregor, JW Locasale, E Lengyel, IL Romero
Molecular cancer research : MCR 2019
Current progress in the inflammatory background of angiogenesis in gynecological cancers
G Szewczyk, TM Maciejewski, D Szukiewicz
Inflammation Research 2019
Ovarian Cancer Dissemination—A Cell Biologist’s Perspective
S Farsinejad, T Cattabiani, T Muranen, M Iwanicki
Cancers 2019
Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target
K Nakamura, K Sawada, M Kobayashi, M Miyamoto, A Shimizu, M Yamamoto, Y Kinose, T Kimura
Cancers 2019
Productive Cross-Talk with the Microenvironment: A Critical Step in Ovarian Cancer Metastasis
Aziz, Agarwal, Dasari, Mitra
Cancers 2019
Quantitative High-Throughput Screening Using an Organotypic Model Identifies Compounds that Inhibit Ovarian Cancer Metastasis
HA Kenny, M Lal-Nag, M Shen, B Kara, DA Nahotko, K Wroblewski, S Fazal, S Chen, CY Chiang, YJ Chen, KR Brimacombe, J Marugan, M Ferrer, E Lengyel
Molecular cancer therapeutics 2019
Mesothelial Cell HIF1α Expression Is Metabolically Downregulated by Metformin to Prevent Oncogenic Tumor-Stromal Crosstalk
PC Hart, HA Kenny, N Grassl, KM Watters, LM Litchfield, F Coscia, I Blaženović, L Ploetzky, O Fiehn, M Mann, E Lengyel, IL Romero
Cell Reports 2019
Ovarian cancer‐associated mesothelial cells induce acquired platinum‐resistance in peritoneal metastasis via the FN1/Akt signaling pathway
M Yoshihara, H Kajiyama, A Yokoi, M Sugiyama, Y Koya, Y Yamakita, W Liu, K Nakamura, Y Moriyama, H Yasui, S Suzuki, Y Yamamoto, C Ricciardelli, A Nawa, K Shibata, F Kikkawa
International Journal of Cancer 2019
Fibrin Deposit on the Peritoneal Surface Serves as a Niche for Cancer Expansion in Carcinomatosis Patients
S Shahid, A Iman, U Matti, K Rachid, A Assaf, C Eveno, P Marc, M Massoud
Neoplasia (New York, N.Y.) 2019
Collagen Remodeling in the Hypoxic Tumor-Mesothelial Niche Promotes Ovarian Cancer Metastasis
S Natarajan, KM Foreman, MI Soriano, NS Rossen, H Shehade, DR Fregoso, JT Eggold, V Krishnan, O Dorigo, AJ Krieg, SC Heilshorn, S Sinha, KC Fuh, EB Rankin
Cancer research 2019
Metastasis Organotropism: Redefining the Congenial Soil
Y Gao, I Bado, H Wang, W Zhang, JM Rosen, XH Zhang
Developmental Cell 2019
Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer
Q Gao, Z Yang, S Xu, X Li, X Yang, P Jin, Y Liu, X Zhou, T Zhang, C Gong, X Wei, D Liu, C Sun, G Chen, J Hu, L Meng, J Zhou, K Sawada, R Fruscio, TW Grunt, J Wischhusen, VM Vargas-Hernández, B Pothuri, RL Coleman
Journal of Experimental Medicine 2019
Mutant p53 regulates LPA signaling through lysophosphatidic acid phosphatase type 6
A Chryplewicz, SM Tienda, DA Nahotko, PN Peters, E Lengyel, MA Eckert
Scientific Reports 2019
Fibronectin in Cancer: Friend or Foe
TC Lin, CH Yang, LH Cheng, WT Chang, YR Lin, HC Cheng
Cells 2019
Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis
S McGuire, B Kara, PC Hart, A Montag, K Wroblewski, S Fazal, XY Huang, E Lengyel, HA Kenny
Gynecologic Oncology 2019
Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts
MA Eckert, F Coscia, A Chryplewicz, JW Chang, KM Hernandez, S Pan, SM Tienda, DA Nahotko, G Li, I Blaženović, RR Lastra, M Curtis, SD Yamada, R Perets, SM McGregor, J Andrade, O Fiehn, RE Moellering, M Mann, E Lengyel
Nature 2019
Therapeutic Targeting of Collective Invasion in Ovarian Cancer
L Moffitt, N Karimnia, A Stephens, M Bilandzic
International journal of molecular sciences 2019
Senescence-related deterioration of intercellular junctions in the peritoneal mesothelium promotes the transmesothelial invasion of ovarian cancer cells
M Pakuła, A Witucka, P Uruski, A Radziemski, R Moszyński, D Szpurek, K Maksin, A Woźniak, S Sajdak, A Tykarski, J Mikuła-Pietrasik, K Książek
Scientific Reports 2019
Presence and role of stem cells in ovarian cancer
NK Suster, I Virant-Klun
World journal of stem cells 2019
An omentum-inspired 3D PEG hydrogel for identifying ECM-drivers of drug resistant ovarian cancer
EA Brooks, MF Gencoglu, DC Corbett, KR Stevens, SR Peyton
2019
Fibronectin in malignancy: Cancer-specific alterations, protumoral effects, and therapeutic implications
JW Rick, A Chandra, CD Ore, AT Nguyen, G Yagnik, MK Aghi
Seminars in Oncology 2019
A Stromal Niche Defined by Expression of the Transcription Factor WT1 Mediates Programming and Homeostasis of Cavity-Resident Macrophages
MB Buechler, KW Kim, EJ Onufer, JW Williams, CC Little, CX Dominguez, Q Li, W Sandoval, JE Cooper, CA Harris, MR Junttila, GJ Randolph, SJ Turley
Immunity 2019
Transcriptome Profiling Reveals Matrisome Alteration as a Key Feature of Ovarian Cancer Progression
S Mitra, K Tiwari, R Podicheti, T Pandhiri, DB Rusch, A Bonetto, C Zhang, AK Mitra
Cancers 2019
A Monoclonal Antibody Against β1 Integrin Inhibits Proliferation and Increases Survival in an Orthotopic Model of High-Grade Meningioma
F Nigim, J Kiyokawa, A Gurtner, Y Kawamura, L Hua, EM Kasper, PK Brastianos, DP Cahill, SD Rabkin, RL Martuza, WS Carbonell, H Wakimoto
Targeted Oncology 2019
Therapeutic effects of Salvia miltiorrhiza injection combined with telmisartan in patients with diabetic nephropathy by influencing collagen IV and fibronectin: A case-control study
JM Nie, HF Li
Experimental and therapeutic medicine 2018
Cancer Associated Fibroblasts: Naughty Neighbors That Drive Ovarian Cancer Progression
S Dasari, Y Fang, AK Mitra
Cancers 2018
Charting the unexplored extracellular matrix in cancer
EC Filipe, JL Chitty, TR Cox
International Journal of Experimental Pathology 2018
The mechanical microenvironment regulates ovarian cancer cell morphology, migration, and spheroid disaggregation
AJ McKenzie, SR Hicks, KV Svec, H Naughton, ZL Edmunds, AK Howe
Scientific Reports 2018
Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis
M Curtis, HA Kenny, B Ashcroft, A Mukherjee, A Johnson, Y Zhang, Y Helou, R Batlle, X Liu, N Gutierrez, X Gao, SD Yamada, R Lastra, A Montag, N Ahsan, JW Locasale, AR Salomon, AR Nebreda, E Lengyel
Cell Metabolism 2018
Role of tumor microenvironment in the pathobiology of ovarian cancer: Insights and therapeutic opportunities
A Ghoneum, H Afify, Z Salih, M Kelly, N Said
Cancer Medicine 2018
Organotypic 3D Models of the Ovarian Cancer Tumor Microenvironment
KM Watters, P Bajwa, HA Kenny
Cancers 2018
Role of tumor microenvironment in ovarian cancer pathobiology
A Ghoneum, H Afify, Z Salih, M Kelly, N Said
Oncotarget 2018
Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis
A Ladanyi, A Mukherjee, HA Kenny, A Johnson, AK Mitra, S Sundaresan, KM Nieman, G Pascual, SA Benitah, A Montag, SD Yamada, NA Abumrad, E Lengyel
Oncogene 2018
Mechanisms and context underlying the role of autophagy in cancer metastasis
CM Dower, CA Wills, SM Frisch, HG Wang
Autophagy 2018
Recent advances in understanding the complexities of metastasis
JL Chitty, EC Filipe, MC Lucas, D Herrmann, TR Cox, P Timpson
F1000Research 2018
Targeting the Microenvironment in High Grade Serous Ovarian Cancer
N Nwani, L Sima, W Nieves-Neira, D Matei
Cancers 2018
ADH1B promotes mesothelial clearance and ovarian cancer infiltration
KM Gharpure, OD Lara, Y Wen, S Pradeep, C LaFargue, C Ivan, R Rupaimoole, W Hu, LS Mangala, SY Wu, AS Nagaraja, K Baggerly, AK Sood
Oncotarget 2018
The Impact of Mesothelin in the Ovarian Cancer Tumor Microenvironment
T Hilliard
Cancers 2018
FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer
H Lai, X Zhao, Y Qin, Y Ding, R Chen, G Li, M Labrie, Z Ding, J Zhou, J Hu, D Ma, Y Fang, Q Gao
Journal of Experimental & Clinical Cancer Research 2018
Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition
Q Li, B Li, Q Li, S Wei, Z He, X Huang, L Wang, Y Xia, Z Xu, Z Li, W Wang, L Yang, D Zhang, Z Xu
Cell Death and Disease 2018
Characterization of the PEGylated Functional Upstream Domain Peptide (PEG-FUD): a Potent Fibronectin Assembly Inhibitor with Potential as an Anti-Fibrotic Therapeutic
P Zbyszynski, BR Tomasini-Johansson, DM Peters, GS Kwon
Pharmaceutical Research 2018
Knockdown of Heparanase Suppresses Invasion of Human Trophoblasts by Activating p38 MAPK Signaling Pathway
G Che, Y Wang, B Zhou, L Gao, T Wang, F Yuan, L Zhang
Disease Markers 2018
Ovarian Tumor Microenvironment Signaling: Convergence on the Rac1 GTPase
L Hudson, J Gillette, H Kang, M Rivera, A Wandinger-Ness
Cancers 2018
Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells
A Yoshimura, K Sawada, K Nakamura, Y Kinose, E Nakatsuka, M Kobayashi, M Miyamoto, K Ishida, Y Matsumoto, M Kodama, K Hashimoto, S Mabuchi, T Kimura
BMC Cancer 2018
Unraveling the Journey of Cancer Stem Cells from Origin to Metastasis
RK Nimmakayala, SK Batra, MP Ponnusamy
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2018
Molecular Mechanisms Regulating Organ-Specific Metastases in Epithelial Ovarian Carcinoma
M Barbolina
Cancers 2018
Fibronectin Regulates the Dynamic Formation of Ovarian Cancer Multicellular Aggregates and the Expression of Integrin Receptors
Lin Gong, Ying Zheng, Shanling Liu, Zhilan Peng
Asian Pacific Journal of Cancer Prevention 2018
Fibrosis of mesothelial cell-induced peritoneal implantation of ovarian cancer cells
J Wang, C Liu, X Chang, Y Qi, Z Zhu, X Yang
Cancer management and research 2018
A Proximal Culture Method to Study Paracrine Signaling Between Cells
S Dasari, T Pandhiri, J Haley, D Lenz, AK Mitra
Journal of visualized experiments : JoVE 2018
The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
T Worzfeld, EP von Strandmann, M Huber, T Adhikary, U Wagner, S Reinartz, R Müller
Frontiers in Oncology 2017
Ovarian and Breast Cancer Migration Dynamics on Laminin and Fibronectin Bi-directional Gradient Fibers Fabricated via Multiphoton Excited Photochemistry
V Ajeti, J Lara-Santiago, S Alkmin, PJ Campagnola
Cellular and Molecular Bioengineering 2017
The peritoneal “soil” for a cancerous “seed”: a comprehensive review of the pathogenesis of intraperitoneal cancer metastases
J Mikuła-Pietrasik, P Uruski, A Tykarski, K Książek
Cellular and Molecular Life Sciences 2017
TGFβ1 in fibroblasts-derived exosomes promotes epithelial-mesenchymal transition of ovarian cancer cells
W Li, X Zhang, J Wang, M Li, C Cao, J Tan, D Ma, Q Gao
Oncotarget 2017
Potential Coagulation Factor-Driven Pro-Inflammatory Responses in Ovarian Cancer Tissues Associated with Insufficient O2 and Plasma Supply
S Koizume, Y Miyagi
International journal of molecular sciences 2017
A loop of cancer-stroma-cancer interaction promotes peritoneal metastasis of ovarian cancer via TNFα-TGFα-EGFR
TS Lau, LK Chan, EC Wong, CW Hui, K Sneddon, TH Cheung, SF Yim, JH Lee, CS Yeung, TK Chung, J Kwong
Oncogene 2017
Ovarian cancer stem cells: still an elusive entity?
M Lupia, U Cavallaro
Molecular Cancer 2017
Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer: Mesothelial-to-mesenchymal transition and peritoneal metastatic niche
A Rynne-Vidal, CL Au-Yeung, JA Jiménez-Heffernan, ML Pérez-Lozano, L Cremades-Jimeno, C Bárcena, I Cristóbal-García, C Fernández-Chacón, TL Yeung, SC Mok, P Sandoval, M López-Cabrera
The Journal of Pathology 2017
A High-Throughput Screening Model of the Tumor Microenvironment for Ovarian Cancer Cell Growth
M Lal-Nag, L McGee, R Guha, E Lengyel, HA Kenny, M Ferrer
SLAS Discovery 2017
Fibronectin: How Its Aberrant Expression in Tumors May Improve Therapeutic Targeting
JP Wang, A Hielscher
Journal of Cancer 2017
Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis
S Xia, C Wang, EL Postma, Y Yang, X Ni, W Zhan
OncoTargets and therapy 2017
Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review
JO van Baal, CJ van Noorden, R Nieuwland, KK de Vijver, A Sturk, WJ van Driel, GG Kenter, CA Lok
Journal of Histochemistry & Cytochemistry 2017
Modeling Ovarian Cancer Multicellular Spheroid Behavior in a Dynamic 3D Peritoneal Microdevice
SS Li, CK Ip, MY Tang, SK Sy, S Yung, TM Chan, M Yang, HC Shum, AS Wong
Journal of visualized experiments : JoVE 2017
Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers
OM Pearce, RM Delaine-Smith, E Maniati, S Nichols, J Wang, S Böhm, V Rajeeve, D Ullah, P Chakravarty, RR Jones, A Montfort, T Dowe, J Gribben, JL Jones, HM Kocher, JS Serody, BG Vincent, J Connelly, JD Brenton, C Chelala, PR Cutillas, M Lockley, C Bessant, MM Knight, FR Balkwill
Cancer Discovery 2017
Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review.
Kobayashi M, Sawada K, Kimura T
Cancers 2017
Mutant p53 Promotes Epithelial Ovarian Cancer by Regulating Tumor Differentiation, Metastasis, and Responsiveness to Steroid Hormones
YA Ren, LK Mullany, Z Liu, AJ Herron, KK Wong, JS Richards
Cancer research 2016
Fibronectin on circulating extracellular vesicles as a liquid biopsy to detect breast cancer
PG Moon, JE Lee, YE Cho, SJ Lee, YS Chae, JH Jung, IS Kim, HY Park, MC Baek
Oncotarget 2016
Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer Cells
F Roggiani, D Mezzanzanica, K Rea, A Tomassetti
International journal of molecular sciences 2016
Fibrotic microenvironment promotes the metastatic seeding of tumor cells via activating the fibronectin 1/secreted phosphoprotein 1-integrin signaling
C Zhang, M Wu, L Zhang, LR Shang, JH Fang, SM Zhuang
Oncotarget 2016
The Role of Mesothelial Cells in Liver Development, Injury, and Regeneration
I Lua, K Asahina
Gut and Liver 2016
Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status
F Coscia, KM Watters, M Curtis, MA Eckert, CY Chiang, S Tyanova, A Montag, RR Lastra, E Lengyel, M Mann
Nature Communications 2016
The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate
KL Boylan, PC Buchanan, RD Manion, DM Shukla, K Braumberger, C Bruggemeyer, AP Skubitz
Oncotarget 2016
Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells
J Mikuła-Pietrasik, P Uruski, K Matuszkiewicz, S Szubert, R Moszyński, D Szpurek, S Sajdak, A Tykarski, K Książek
Cellular Oncology 2016
Cooperative effects of fibronectin matrix assembly and initial cell–substrate adhesion strength in cellular self-assembly
JR Brennan, DC Hocking
Acta Biomaterialia 2016
Senescent peritoneal mesothelium creates a niche for ovarian cancer metastases
J Mikuła-Pietrasik, P Uruski, P Sosińska, K Maksin, H Piotrowska-Kempisty, M Kucińska, M Murias, S Szubert, A Woźniak, D Szpurek, S Sajdak, K Piwocka, A Tykarski, K Książek
Cell Death and Disease 2016
Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform
Y Zhang, SK Sriraman, HA Kenny, E Luther, V Torchilin, E Lengyel
Molecular cancer therapeutics 2016
Diverse properties of the mesothelial cells in health and disease
K Kawanishi
Pleura and Peritoneum 2016
Mechanisms and Targets Involved in Dissemination of Ovarian Cancer
H. WEIDLE U, BIRZELE F, KOLLMORGEN G, RUEGER R
Cancer genomics & proteomics 2016
The Extracellular Matrix in Epithelial Ovarian Cancer – A Piece of a Puzzle
A Cho, VM Howell, EK Colvin
Frontiers in Oncology 2015
EMT-Inducing Molecular Factors in Gynecological Cancers
L Campo, C Zhang, EK Breuer
BioMed Research International 2015
Pathophysiological role of microRNA-29 in pancreatic cancer stroma
JJ Kwon, SC Nabinger, Z Vega, SS Sahu, RK Alluri, Z Abdul-Sater, Z Yu, J Gore, G Nalepa, R Saxena, M Korc, J Kota
Scientific Reports 2015
Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy
HA Kenny, M Lal-Nag, EA White, M Shen, CY Chiang, AK Mitra, Y Zhang, M Curtis, EM Schryver, S Bettis, A Jadhav, MB Boxer, Z Li, M Ferrer, E Lengyel
Nature Communications 2015
Molecular Pathways: Trafficking of Metabolic Resources in the Tumor Microenvironment
IL Romero, A Mukherjee, HA Kenny, LM Litchfield, E Lengyel
Clinical cancer research 2015
Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis
TL Yeung, CS Leung, KP Yip, CL Yeung, ST Wong, SC Mok
American journal of physiology. Cell physiology 2015
The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis
A Rynne-Vidal, J Jiménez-Heffernan, C Fernández-Chacón, M López-Cabrera, P Sandoval
Cancers 2015
Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity
PN Peters, EM Schryver, E Lengyel, H Kenny
Journal of visualized experiments : JoVE 2015
Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis
AK Mitra, CY Chiang, P Tiwari, S Tomar, KM Watters, ME Peter, E Lengyel
Oncogene 2015
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast, V Beral, JS Berek, MJ Birrer, S Blagden, MA Bookman, JD Brenton, KB Chiappinelli, FC Martins, G Coukos, R Drapkin, R Edmondson, C Fotopoulou, H Gabra, J Galon, C Gourley, V Heong, DG Huntsman, M Iwanicki, BY Karlan, A Kaye, E Lengyel, DA Levine, KH Lu, IA McNeish, U Menon, SA Narod, BH Nelson, KP Nephew, P Pharoah, DJ Powell, P Ramos, IL Romero, CL Scott, AK Sood, EA Stronach, FR Balkwill
Nature Reviews Cancer 2015
Role of EGFR expression levels in the regulation of integrin function by EGF: EGFR LEVELS REGULATE INTEGRIN ACTIVATION
D Vial, PJ McKeown-Longo
Molecular Carcinogenesis 2015
Sphingosine kinase 1 is required for TGF-β mediated fibroblast-to-myofibroblast differentiation in ovarian cancer
Beach JA, Aspuria PJ, Cheon DJ, Lawrenson K, Agadjanian H, Walsh CS, Karlan BY, Orsulic S
Oncotarget 2015
Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism
E Torchiaro, A Lorenzato, M Olivero, D Valdembri, PA Gagliardi, M Gai, J Erriquez, G Serini, MF di Renzo
Oncotarget 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 3 … 8 9 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 3 news outlets
Posted by 2 X users
211 readers on Mendeley
See more details